| abstract |
This invention discloses synergistic nutraceutical or pharmaceutical anti-inflammatory compositions or anti-inflammatory compositions of dietary supplements containing a therapeutically effective combination of an extract selectively enriched with 3-O-acetyl-11-keto-β-boswellic acid (AKBA) obtained from Boswellia serrata and an extract of non-acidic resin Boswellia serrata (BNRE). The composition (s) can be used to prevent, control and treat inflammation and some diseases associated with inflammation, including the following: asthma, osteoarthritis, rheumatoid arthritis, endothelial dysfunction and the like. The invention further discloses a decrease in the intensity of pro-inflammatory biomarker proteins or molecules whose expression / production changes during inflammatory diseases. |